Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Idera Pharmaceuticals Inc patents

Recent patent applications related to Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Idera Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Idera Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Idera Pharmaceuticals Inc-related inventors




Date Idera Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
05/25/17Compositions for inhibiting nlrp3 gene expression and uses thereof
05/25/17Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
01/12/17Compositions for inhibiting dux4 gene expression and uses thereof
10/27/16Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
09/01/16Compositions for inhibiting checkpoint gene expression and uses thereof
08/18/16Toll-like receptor 9 antagonist and methods of use thereof
07/28/16Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
07/14/16Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/19/16Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
04/14/16Treatment of cancer using tlr9 agonist with checkpoint inhibitors
02/12/15Compositions for inhibiting gene expression and uses thereof
07/10/14Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
01/02/14Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
10/10/13Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
08/08/13Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
06/06/13Compositions for inhibiting gene expression and uses thereof
08/09/12Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
07/19/12Stabilized immune modulatory rna (simra) compounds
05/24/12Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/03/12Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
02/09/12Novel agonists of toll-like receptor 3 and methods of their use
01/19/12Compositions for inhibiting gene expression and uses thereof
12/22/11Novel synthetic agonists of tlr9
12/15/11Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
12/01/11Novel synthetic agonists of tlr9
09/22/11Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
07/14/11Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9
06/30/11Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
06/23/11Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
06/09/11Synthetic agonists of tlr9
04/07/11Compositions for inhibiting gene expression and uses thereof
03/10/11Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
01/13/11Oligonucleotide-based compounds as inhibitors of toll-like receptors
10/07/10Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
08/26/10Synthetic rna-based agonists of tlr7
08/26/10Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo) containing different lengths of palindromic segments
07/01/10Immunostimulatory oligonucleotide multimers
07/01/10Modulation of immunostimulatory properties by small oligonucleotide-based compounds
05/06/10Modulation of toll-like receptor 2 expression by antisense oligonucleotides
05/06/10Modulation of toll-like receptor 4 expression by antisense oligonucleotides
05/06/10Modulation of toll-like receptor 5 expression by antisense oligonucleotides
04/22/10Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
04/15/10Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides
02/25/10Modulation of toll-like receptor 8 expression by antisense oligonucleotides
02/18/10Modulation of toll-like receptor 7 expression by antisense oligonucleotides
02/18/10Modulation of toll-like receptor 3 expression by antisense oligonucleotides
02/11/10Modulation of toll-like receptor 9 expression by antisense oligonucleotides
04/16/09Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
04/02/09Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
03/26/09Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
03/05/09Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
02/26/09Stabilized immune modulatory rna (simra) compounds
02/26/09Toll like receptor modulators
02/26/09Novel synthetic agonists of tlr9







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Idera Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Idera Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';